The Food and Drug Administration (FDA) has expanded the approval of Bimzelx (bimekizumab-bkzx) to include 3 new indications.

UCB (OTCPK:UCBJY) (OTCPK:UCBJF) said it has received FDA approval for its drug Bimzelx for the treatment of active psoriatic ...

Less than a year after snagging its first FDA approval in psoriasis, UCB’s blockbuster hopeful Bimzelx has picked up three ...

UCB, a global biopharmaceutical company, today announced the presentation of new four-year data in patients with moderate-to-severe plaque psoriasis treated with BIMZELX® (bimekizumab-bkzx), an ...

Biopharmaceutical company UCB has received US Food and Drug Administration (FDA) approval for BIMZELX (bimekizumab-bkzx) to ...

Bimekizumab-bkzx (Bimzelx) is now FDA approved for 4 chronic immune-mediated inflammatory diseases: psoriatic arthritis, nonradiographic axial spondyloarthritis (axSpA), ankylosing spondylitis, and ...

The US Food and Drug Administration has approved bimekizumab -bkzx (Bimzelx; UCB) for adult patients with active psoriatic ...

MDedge News, April 09, 2024 FDA Accepts Application for a New HS Treatment Bimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults ...

A woman has bravely shared how her severe psoriasis made her dread simple activities like showering and socialising with friends. Hannah Boniface, a 25-year-old property management administrator ...

At my worst, I was covered on 90% of my body. The only thing that was not affected by psoriasis was my face. Before I was diagnosed, my grandmother noticed patches on my knees and elbows ...

Psoriasis in the ears can cause irritated, dry skin. The buildup of scales or wax can even lead to temporary hearing loss. If you’re having hearing issues, seek medical help before inserting ...